A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial—the first platform trial for amyotrophic lateral sclerosis (ALS)—designed to accelerate the development of effective and breakthrough treatments for people with the illness.
Adaptive platform trial hopes to bring new treatments to patients faster
A new paper in Annals of Neurology describes the approach, structure, and launch of the HEALEY ALS Platform Trial—the first platform trial for amyotrophic lateral sclerosis (ALS)—designed to accelerate the development of effective and breakthrough treatments for people with the illness.